Although the mechanism of action of cardiac glycosides is unclear, digoxin treatment suppresses neovascularization by decreasing HIF-1α levels in P493 and PC3 tumor xenografts in vivo [59]. The gene discussed is HIF1A; the disease is neoplasm.